Clinical Trials Sponsored by ViraCor Laboratories

Total 2256 results

Upsher-Smith Laboratories

Completed

An Efficacy and Safety Study of DFN-02 (Sumatriptan Nasal Spray 10 mg)

Migraine Headaches

United States
Center Laboratories, Inc.

Completed

CS02 vs Placebo With Metformin in Type 2 Diabetes Mellitus (T2DM)

T2DM With Inadequate Glycemic Control

Taiwan, United States
Concordia Laboratories Inc.

Completed

Feasibility Study of Using Navigational Bronchoscopy to Perform PDT-Photofrin® in Unresectable Peripheral Lung Cancer

Non-small Cell Lung Cancer (NSCLC) | Lung Metastasis

United States, Canada
Concordia Laboratories Inc.

Completed

Safety of PDT-Photofrin® Prior to Lung Surgery

Lung Cancer | Lung Cancer Metastatic

United States
Impax Laboratories, LLC

Completed

A Study to Compare Pharmacokinetics and Pharmacodynamics of IPX066 to Standard Carbidopa-Levodopa

Parkinson's Disease

United States
Impax Laboratories, LLC

Completed

Pharmacokinetics and Pharmacodynamics of IPX054 in Subjects With Parkinson's Disease

Idiopathic Parkinson's Disease

United States
Impax Laboratories, LLC

Completed

Comparison of IPX054, IR Carbidopa-Levodopa, and CR Carbidopa-Levodopa in Subjects With Parkinson's Disease

Idiopathic Parkinson's Disease

United States
Charleston Laboratories, Inc

Completed

A Study in Opioid-Experienced, Non-Dependent Recreational Drug Users to Determine the Abuse Potential and Safety of CL-108 Tablets Administered Via the Oral Route

Pain | Nausea | Vomiting
Center Laboratories, Inc.

Terminated

R-Verapamil for the Prophylaxis of Episodic Cluster Headache

Episodic Cluster Headache

United Kingdom
Romark Laboratories L.C.

Completed

Trial to Evaluate the Efficacy and Safety of Nitazoxanide in the Treatment of Acute Uncomplicated Influenza

Influenza

United States, Australia, Puerto Rico
Pfizer
Forest Laboratories

Completed

Ceftazidime-Avibactam for the Treatment of Infections Due to Ceftazidime Resistant Pathogens

Complicated Intra-abdominal Infection | Complicated Urinary Tract Infection

Croatia, Bulgaria, Korea, Republic of, Mexico, Peru, Russian Federation, Spain, Turkey, Poland, Romania, Ukraine, South Africa, Argentina, Israel, United States, Philippines, France, Czechia
Pfizer
Forest Laboratories

Terminated

Evaluation of Ceftaroline Fosamil vs Vancomycin Plus Aztreonam in the Treatment of Patients With Skin Infections.

Complicated Skin and Soft Tissue Infection

Croatia, Bulgaria, Italy, Turkey, Romania, Argentina, Brazil, Chile, Israel, Poland, South Africa, Greece, Spain
Pfizer
Forest Laboratories

Completed

Ceftazidime-Avibactam Compared With Doripenem Followed by Oral Therapy for Hospitalized Adults With Complicated UTIs (Urinary Tract Infections)

Complicated Urinary Tract Infection (cUTI) Including Acute Pyelonephritis

Croatia, Bulgaria, Korea, Republic of, Mexico, Peru, Poland, Russian Federation, Spain, Romania, Ukraine, United States, Argentina, Czechia, Israel, Taiwan, Germany, Italy
Rovi Pharmaceuticals Laboratories

Completed

Pharmacokinetics and Tolerability Study of Risperidone ISM® in Schizophrenia (PRISMA-2)

Schizophrenia

United States
Bio-Rad Laboratories

Completed

Performance Evaluation of the Bio-Rad Geenius HIV1/2 Supplemental Assay

HIV

United States
Elite Laboratories, Inc

Completed

A Study to Evaluate Withdrawal Effects Following Dosing of Oxycodone/Naltrexone in Methadone-Maintained Subjects

Withdrawal Symptoms

United States
Elite Laboratories, Inc

Completed

A Study to Evaluate Safety and Efficacy Following Dosing of Oxycodone/Naltrexone for Treatment of Adults With Pain Following Bunionectomy Surgery

Pain

United States
Forest Laboratories
AstraZeneca

Completed

Evaluation of Ceftaroline Fosamil Versus a Comparator in Adult Subjects With Community-acquired Bacterial Pneumonia (CABP) With Risk for Methicillin-resistant Staphylococcus Aureus

Infections

Poland, Romania, Russian Federation, Ukraine, Georgia, Hungary, United States, Spain
Romark Laboratories L.C.

Terminated

Study of Nitazoxanide in the Treatment of Clostridium Difficile-associated Disease

Clostridium Infections

United States
Upsher-Smith Laboratories

Completed

Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures

Epilepsy

Australia, Canada, Poland, United States, Belgium, Spain, Argentina, Israel, India, South Africa, Greece, Russian Federation, Chile, New Zealand, Germany
Forest Laboratories
AstraZeneca

Completed

Safety and Efficacy Study of Ceftaroline Versus a Comparator in Pediatric Subjects With Complicated Skin Infections

Infections, Pediatrics

United States, Argentina, Chile, Georgia, Latvia, Lithuania, Poland, Romania, South Africa, Spain
Upsher-Smith Laboratories

Completed

Study to Evaluate the Safety and Effectiveness of USL255 in Patients With Refractory Partial-onset Seizures

Epilepsy

United States, Australia, Poland, Belgium, Spain, Argentina, Israel, India, South Africa, Greece, Russian Federation, Chile, Germany, New Zealand, Hungary, Canada
Antigen Laboratories, Inc.

Completed

Phase 2 Study in Adults Sensitized to Cat

Allergy

United States
Rovi Pharmaceuticals Laboratories

Completed

Pharmacokinetics, Safety, and Tolerance Study of Single Dose Administration of Risperidone ISM®

Healthy
Ferozsons Laboratories Ltd.

Unknown

Role of ProTectis on Infant Colic and Its Effect on Infant Crying Time and Maternal Mental Health (PRIC-SMM)

Infantile Colic | Infant Sleeping Habits | Maternal Mental Health.

Pakistan
Romark Laboratories L.C.

Completed

Study of Nitazoxanide, Peginterferon Alfa-2a and Ribavirin in Treatment-Naive Hepatitis C Patients (STEALTHC-3)

Chronic Hepatitis C

United States
Nova Laboratories Limited

Completed

Bioequivalence of An Oral Mercaptopurine Suspension 100 Mg / 5 Ml Versus Tablet in Healthy Male Subjects Under Fasting Conditions

Acute Lymphoblastic Leukemia

South Africa
IPCA Laboratories Ltd.

Completed

Bioequivalence Study of Lisinopril and Hydrochlorothiazide Tablets (20+25) mg Under Fasting Conditions

Fasting

India
IPCA Laboratories Ltd.

Completed

Bioequivalence Study of Etodolac Capsules USP 300 mg Under Fed Condition

Healthy

India
IPCA Laboratories Ltd.

Completed

Bioequivalence Study of Etodolac Capsules USP 300 mg Under Fasting Condition

Fasting

India
IPCA Laboratories Ltd.

Completed

Bioequivalence Study of Bisoprolol Fumarate Tablet 10 mg Under Fed Condition

Fed

India
IPCA Laboratories Ltd.

Completed

Bioequivalence Study of Bisoprolol Fumarate Tablet 10 mg Under Fasting Condition

Fasting

India
IPCA Laboratories Ltd.

Completed

Bioequivalence Study of Etodolac Tablet USP 500 mg Under Fasting Condition

Fasting

India
IPCA Laboratories Ltd.

Completed

Bioequivalence Study of Quetiapine Fumarate Tablets 25 mg Under Fed Condition

Fed

India
IPCA Laboratories Ltd.

Completed

Bioequivalence Study of Carvedilol Tablets USP 12.5 mg Under Fasting Condition

Fasting State

India
Romark Laboratories L.C.

Terminated

Study of Nitazoxanide Tablets in the Treatment of Mild to Moderate Active Crohn's Disease

Crohn's Disease

United States
Romark Laboratories L.C.

Completed

Study of Nitazoxanide Suspension in the Treatment of Diarrhea Caused by Enteric Viruses in Children

Rotavirus Infection | Norovirus Infection | Adenoviridae Infection
IPCA Laboratories Ltd.

Completed

Bioequivalence Study of Ondansetron Tablets USP 8 mg Under Fed Condition

Fed

India
IPCA Laboratories Ltd.

Completed

Bioequivalence Study of Ondansetron Tablets USP 8 mg Under Fasting Condition

Fasting State

India
Ferozsons Laboratories Ltd.

Unknown

Study to Assess Efficacy of Nicorandil+Atenolol vs Atenolol in Treatment of Chronic Stable Angina.

Chronic Stable Angina

Pakistan
Forest Laboratories
Phenomix

Terminated

Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus Receiving Background Treatment With Glimepiride Alone or in Combination With Metformin or With Pioglitazone Alone (REDWOOD403)

Diabetes Mellitus, Type 2

United States
Oakwood Laboratories, LLC

Completed

Safety and Efficacy Study of Leuprolide Acetate for Injectable Suspension 22.5 MG in the Treatment of Prostate Cancer

Prostate Cancer

United States
Phenomix
Forest Laboratories

Terminated

Long-term Study to Evaluate the Safety of Dutogliptin/PHX1149T in Subjects With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus | Type 2 Diabetes

United States, Malaysia, Peru, India, Argentina, Philippines, Romania, Ukraine
Phenomix
Forest Laboratories

Terminated

Safety and Efficacy Study of Dutogliptin/PHX1149T in Subjects With Type 2 Diabetes Mellitus on a Background Medication of Metformin

Type 2 Diabetes Mellitus

United States, Argentina, Chile, Czech Republic, India, Peru, Poland
Phenomix
Forest Laboratories

Terminated

Safety and Efficacy Study of Dutogliptin in Subjects With Type 2 Diabetes Mellitus on a Background Medication of Metformin

Type 2 Diabetes Mellitus

United States, Argentina, India, Peru, Poland, Czech Republic
Rovi Pharmaceuticals Laboratories

Completed

CANBESURE STUDY (Cancer, Bemiparin and Surgery Evaluation)

Cancer | Venous Thromboembolism

Spain, Portugal, Romania, Russian Federation
Phenomix
Forest Laboratories

Completed

Safety and Efficacy Study of Dutogliptin/PHX1149T to Treat Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

United States, Ukraine, Argentina, Malaysia, India, Romania, Thailand, Philippines, Peru
Romark Laboratories L.C.

Completed

4-Week Lead-In With Nitazoxanide Followed by 36 Weeks Nitazoxanide and Peginterferon Alfa-2a in Chronic Hepatitis C

Chronic Hepatitis C

Egypt
Upsher-Smith Laboratories

Completed

Study to Evaluate Divigel for the Treatment of Postmenoupausal Symptoms

Postmenopausal Symptoms
Oakwood Laboratories, LLC

Completed

Clinical Trial for Prostate Cancer

Prostate Cancer

Clinical Trials Sponsored by ViraCor Laboratories

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Italy

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations